Sector Expert: Robin Davison

Edison Investment Research



Recent Quotes

"The central element of ADXN's revised strategy is to advance its clinical-stage candidates."

— Robin Davison, Edison Investment Research (3/5/13)
more >

"ADXN's coming phase II studies could catalyze a significant increase in value."

— Robin Davison, Edison Investment Research (1/4/12)
more >

"ADXN has the potential to generate high-value product opportunities."

— Robin Davison, Edison Investment Research (9/6/11)
more >

"ADXN's new CEO has experience and a strong track record."

— Robin Davison, Edison Investment Research (8/16/11)
more >



Due to permission requirements, not all quotes are shown.